• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Visceral Leishmaniasis in Sub-Himalayan India (1967-2023): A Systematic Review.印度次喜马拉雅地区内脏利什曼病(1967-2023):系统评价。
Am J Trop Med Hyg. 2024 Aug 27;111(5):928-933. doi: 10.4269/ajtmh.24-0036. Print 2024 Nov 6.
2
Interventions for Old World cutaneous leishmaniasis.旧世界皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2017 Dec 1;12(12):CD005067. doi: 10.1002/14651858.CD005067.pub5.
3
Interventions for Old World cutaneous leishmaniasis.旧世界皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2017 Nov 17;11(11):CD005067. doi: 10.1002/14651858.CD005067.pub4.
4
Implication of vector characteristics of Phlebotomus argentipes in the kala-azar elimination programme in the Indian sub-continent.印度次大陆银足白蛉的媒介特性在黑热病消除计划中的意义。
Pathog Glob Health. 2016 May;110(3):87-96. doi: 10.1080/20477724.2016.1180775.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
8
Demographic and Clinical Features of Visceral Leishmaniasis in Chad: A Prospective Cross-Sectional Survey.乍得内脏利什曼病的人口统计学和临床特征:一项前瞻性横断面调查
Am J Trop Med Hyg. 2024 Oct 1;111(6):1192-1197. doi: 10.4269/ajtmh.23-0033. Print 2024 Dec 4.
9
A clinico-epidemiological study, assessing possible predictors of mortality and health-related quality of life for people living with visceral leishmaniasis - human immune virus (VL-HIV) co-infection in a high burden kala-azar endemic state of India: a descriptive cross-sectional study.一项临床流行病学研究,评估印度黑热病高负担流行地区内脏利什曼病与人类免疫病毒(VL-HIV)合并感染患者的死亡率及健康相关生活质量的可能预测因素:一项描述性横断面研究。
BMC Infect Dis. 2025 Jul 2;25(1):887. doi: 10.1186/s12879-025-10768-y.
10
Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004.内脏利什曼病的治疗选择:对1980 - 2004年在印度开展的临床研究的系统评价
Lancet Infect Dis. 2005 Dec;5(12):763-74. doi: 10.1016/S1473-3099(05)70296-6.

引用本文的文献

1
Global, regional, and national burden of Visceral leishmaniasis, 1990-2021: findings from the global burden of disease study 2021.1990-2021年全球、区域和国家内脏利什曼病负担:全球疾病负担研究2021的结果
Parasit Vectors. 2025 Apr 26;18(1):157. doi: 10.1186/s13071-025-06796-x.

本文引用的文献

1
Emerging pediatric visceral leishmaniasis in Kashmir valley: A report of three cases.克什米尔山谷地区新出现的儿童内脏利什曼病:三例报告。
Trop Doct. 2023 Apr;53(2):317-318. doi: 10.1177/00494755231153244. Epub 2023 Jan 24.
2
Visceral leishmaniasis outbreak in Kenya-a setback to the elimination efforts.肯尼亚内脏利什曼病疫情——消除工作的挫折
New Microbes New Infect. 2022 Nov 29;49-50:101060. doi: 10.1016/j.nmni.2022.101060. eCollection 2022 Nov-Dec.
3
An intraspecies hybrid from the Indian subcontinent is associated with an atypical phenotype of cutaneous disease.来自印度次大陆的种内杂交种与一种非典型的皮肤疾病表型有关。
iScience. 2022 Jan 22;25(2):103802. doi: 10.1016/j.isci.2022.103802. eCollection 2022 Feb 18.
4
Pediatric Cutaneous Leishmaniasis: A Clinico-Epidemiological Study from North India.儿童皮肤利什曼病:来自印度北部的一项临床流行病学研究。
Indian Dermatol Online J. 2021 Nov 22;12(6):852-859. doi: 10.4103/idoj.IDOJ_49_21. eCollection 2021 Nov-Dec.
5
Detection of Leishmania donovani in Wild-Caught Phlebotomine Sand Flies in Endemic Focus of Leishmaniasis in Himachal Pradesh, India.在印度喜马偕尔邦利什曼病流行地区的野生嗜人按蚊中检测到杜氏利什曼原虫。
J Med Entomol. 2022 Mar 16;59(2):719-724. doi: 10.1093/jme/tjab202.
6
Towards the elimination of visceral leishmaniasis as a public health problem in east Africa: reflections on an enhanced control strategy and a call for action.为消除东非地区内脏利什曼病这一公共卫生问题:对强化控制策略的思考和行动呼吁。
Lancet Glob Health. 2021 Dec;9(12):e1763-e1769. doi: 10.1016/S2214-109X(21)00392-2.
7
India's performance in controlling Visceral Leishmaniasis as compared to Brazil over past three decades: findings from global burden of disease study.过去三十年印度与巴西在控制内脏利什曼病方面的表现:全球疾病负担研究结果
J Parasit Dis. 2021 Dec;45(4):877-886. doi: 10.1007/s12639-021-01375-0. Epub 2021 Mar 18.
8
Epidemiology of Post-Kala-azar Dermal Leishmaniasis.黑热病后皮肤利什曼病的流行病学
Indian J Dermatol. 2021 Jan-Feb;66(1):12-23. doi: 10.4103/ijd.IJD_651_20.
9
Leishmania donovani Infection with Atypical Cutaneous Manifestations, Himachal Pradesh, India, 2014-2018.2014-2018 年,印度喜马偕尔邦出现不典型皮肤表现的杜氏利什曼原虫感染。
Emerg Infect Dis. 2020 Aug;26(8):1864-1869. doi: 10.3201/eid2608.191761.
10
Rising visceral leishmaniasis in Holy Himalayas (Uttarakhand, India) - A cross-sectional hospital-based study.印度北阿坎德邦喜马拉雅圣地内脏利什曼病发病率上升——一项基于医院的横断面研究。
J Family Med Prim Care. 2020 Mar 26;9(3):1362-1369. doi: 10.4103/jfmpc.jfmpc_1174_19. eCollection 2020 Mar.

印度次喜马拉雅地区内脏利什曼病(1967-2023):系统评价。

Visceral Leishmaniasis in Sub-Himalayan India (1967-2023): A Systematic Review.

机构信息

Department of Medical Parasitology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.

出版信息

Am J Trop Med Hyg. 2024 Aug 27;111(5):928-933. doi: 10.4269/ajtmh.24-0036. Print 2024 Nov 6.

DOI:10.4269/ajtmh.24-0036
PMID:39191237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11542517/
Abstract

Substantial gains have been achieved in the control of visceral leishmaniasis (VL) in the four endemic states of India; however, cases are sporadically reported from other nonendemic regions of India such as the sub-Himalayan region, which can be a hurdle to VL elimination. We analyzed VL reports published from the sub-Himalayan regions of India over seven decades (1967-2023) in this systematic review. Medline, Embase, Scopus, and Web of Science were searched for VL cases from sub-Himalayan regions of India. The demographic data, clinical presentation, diagnostic modality, treatment, outcomes of the cases, and overall year-wise and geographical distribution of the cases were analyzed; studies on the sand fly vector were also included. From 535 articles, 33 studies were included in the analysis. Overall, 228 patients were diagnosed with VL in the sub-Himalayan region of India from 1967 to 2023. These cases were reported from Uttarakhand (n = 178), Himachal Pradesh (n = 39), and Jammu and Kashmir (n = 11). Most patients (88.4%) did not have a history of travel outside their native places. Three pediatric cases were reported from Jammu and Kashmir. The DNA of Leishmania donovani was detected in four of the 52 (7.7%) sand flies collected from Himachal Pradesh. The published literature points toward the existence of local transmission of VL in the sub-Himalayan region of India, strongly substantiated by the emergence of pediatric VL in some places. Thus, these difficult-to-reach hilly states of India will require focused surveillance for VL to successfully achieve elimination goals.

摘要

印度四个流行内脏利什曼病(VL)的邦已经取得了显著进展;然而,在印度其他非流行地区,如喜马拉雅山脉下地区,也有零星报告病例,这可能是消除 VL 的一个障碍。我们在本系统评价中分析了印度喜马拉雅山脉下地区 70 多年(1967-2023 年)发表的 VL 报告。我们在 Medline、Embase、Scopus 和 Web of Science 上搜索了来自印度喜马拉雅山脉下地区的 VL 病例。分析了病例的人口统计学数据、临床表现、诊断方式、治疗、病例结局以及病例的总体年度和地理分布;还包括对沙蝇媒介的研究。从 535 篇文章中,有 33 项研究纳入了分析。总体而言,从 1967 年到 2023 年,印度喜马拉雅山脉下地区共诊断出 228 例 VL 病例。这些病例来自北阿坎德邦(n=178)、喜马偕尔邦(n=39)和查谟和克什米尔邦(n=11)。大多数患者(88.4%)没有在当地以外旅行的病史。有 3 例儿科病例来自查谟和克什米尔。从喜马偕尔邦采集的 52 只沙蝇中,有 4 只(7.7%)检测到利什曼原虫 DNA。已发表的文献表明,印度喜马拉雅山脉下地区存在 VL 的本地传播,某些地方出现儿科 VL 病例进一步证实了这一点。因此,印度这些难以到达的丘陵州将需要对 VL 进行重点监测,以成功实现消除目标。